IMO, the reasons for the maximum amount of time being used by the FDA in their decision making process, are twofold. ———
First, reviewing and verifying Trial Data takes an enormous amount of time…it is TRULY a Herculean effort to accomplish this task for a Fast Track Therapeutic. We’re approaching 60-days at the end of this week, and being among the group of Fast Track Therapeutics, we should technically have our answer by Friday. “Technically.” ———
Second, and likely equally important, the FDA and the current Presidential Administration would like to have as many people as possible vaccinated before rolling out a truly efficacious (i.e., unlike Remdesivir) COVID Therapeutic. ———
Posit: If you were an anti-vaxer, how likely would it be that you would EVER consider a SARS Co-V-2 vaccine knowing there is a Therapeutic (i.e., Zyesami/Aviptadil) that is highly likely to cure you of COVID should you become ill? ———
Answer: Highly unlikely. ———
And while Zyesami/Aviptadil WILL cure many…not necessarily all, especially among those with complicating comorbidities, but many will be cured…then that leaves a WHOLE Lot of unvaccinated people who are free to continue distributing/infecting the general public at large everywhere they go until they themselves develop COVID symptoms, and can be treated by our little Gem here. ———
I’m curious as to what you all may think/feel about my squirrelly ?? notions. I’m on vacation with my family, so I won’t be able to reply until later this evening. But my “Thanks” to all in advance for your thoughts on these matters. ———
And, for the Longs here…we’ve all done our DD. We know what we own. Don’t be frazzled by all of the “tools” here in large numbers trying to separate us from our invested dollars/Francs on a daily basis. I truly do believe it’s simply a waiting game at this point. ———
—Cheers—
~~~ Brian A, from Y@h00 RLFTF finance conversations
